505 related articles for article (PubMed ID: 32315205)
1. The Obstacle Course of Reperfusion for ST-Segment-Elevation Myocardial Infarction in the COVID-19 Pandemic.
Roffi M; Guagliumi G; Ibanez B
Circulation; 2020 Jun; 141(24):1951-1953. PubMed ID: 32315205
[No Abstract] [Full Text] [Related]
2. Reperfusion of ST-Segment-Elevation Myocardial Infarction in the COVID-19 Era: Business as Usual?
Daniels MJ; Cohen MG; Bavry AA; Kumbhani DJ
Circulation; 2020 Jun; 141(24):1948-1950. PubMed ID: 32282225
[No Abstract] [Full Text] [Related]
3. Effect of the COVID-19 Pandemic on ST-Segment-Elevation Myocardial Infarction Presentations and In-Hospital Outcomes.
Wilson SJ; Connolly MJ; Elghamry Z; Cosgrove C; Firoozi S; Lim P; Sharma R; Spratt JC
Circ Cardiovasc Interv; 2020 Jul; 13(7):e009438. PubMed ID: 32600109
[No Abstract] [Full Text] [Related]
4. COVID-19 pandemic and the reduction in ST-elevation myocardial infarction admissions.
Kulkarni P; Mahadevappa M
Postgrad Med J; 2020 Jul; 96(1137):436-437. PubMed ID: 32522847
[No Abstract] [Full Text] [Related]
5. No Reduction of ST-segment Elevation Myocardial Infarction Admission in Taiwan During Coronavirus Pandemic.
Li YH; Huang WC; Hwang JJ;
Am J Cardiol; 2020 Sep; 131():133-134. PubMed ID: 32713656
[No Abstract] [Full Text] [Related]
6. ST-Segment-Elevation Myocardial Infarction Care and COVID-19: The Value Proposition of Fibrinolytic Therapy and the Pharmacoinvasive Strategy.
Bainey KR; Bates ER; Armstrong PW
Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006834. PubMed ID: 32339038
[No Abstract] [Full Text] [Related]
7. Decrease in ST-segment elevation myocardial infarction admissions in Catalonia during the COVID-19 pandemic.
Romaguera R; Ribera A; Güell-Viaplana F; Tomás-Querol C; Muñoz-Camacho JF; Agudelo V;
Rev Esp Cardiol (Engl Ed); 2020 Sep; 73(9):778-780. PubMed ID: 32565077
[No Abstract] [Full Text] [Related]
8. Primary Percutaneous Coronary Intervention or Fibrinolytic Therapy in COVID 19 Patients Presenting With ST-Segment Elevation Myocardial Infarction.
Sudhakar D; Jneid H; Lakkis N; Kayani WT
Am J Cardiol; 2020 Nov; 134():158. PubMed ID: 32841613
[No Abstract] [Full Text] [Related]
9. Centralization of the ST elevation myocardial infarction care network in the Lombardy region during the COVID-19 outbreak.
Ferlini M; Andreassi A; Carugo S; Cuccia C; Bianchini B; Castiglioni B; D' Urbano M; Guagliumi G; Lettieri C; Lettino M; Marenzi G; Metra M; Migliori M; Montorfano M; Oliva F; Savonitto S; Seregni R; Visconti LO
Int J Cardiol; 2020 Aug; 312():24-26. PubMed ID: 32339543
[No Abstract] [Full Text] [Related]
10. Assessment of ST-Segment Elevation Myocardial Infarction Volume Trends During The COVID-19 Pandemic.
Lotfi AS; Capatina A; Kugelmass AD
Am J Cardiol; 2020 Sep; 131():132-133. PubMed ID: 32732009
[No Abstract] [Full Text] [Related]
11. Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic.
Yerasi C; Case BC; Forrestal BJ; Chezar-Azerrad C; Hashim H; Ben-Dor I; Satler LF; Mintz GS; Waksman R
Cardiovasc Revasc Med; 2020 Aug; 21(8):1024-1029. PubMed ID: 32471712
[TBL] [Abstract][Full Text] [Related]
12. Impact of COVID-19 on reperfusion strategies for acute coronary syndromes.
Torres-Escobar G; González-Pacheco H; Cruz JLB; Arias-Mendoza A; Araiza-Garaygordobil D
Arch Cardiol Mex; 2020; 90(Supl):62-66. PubMed ID: 32523136
[TBL] [Abstract][Full Text] [Related]
13. Impact of COVID-19 pandemic on patients with ST-segment elevation myocardial infarction: Insights from a British cardiac center.
Abdelaziz HK; Abdelrahman A; Nabi A; Debski M; Mentias A; Choudhury T; Patel B; Saad M
Am Heart J; 2020 Aug; 226():45-48. PubMed ID: 32497914
[TBL] [Abstract][Full Text] [Related]
14. Patient and Provider Risk in Managing ST-Elevation Myocardial Infarction During the COVID-19 Pandemic: A Decision Analysis.
Butala NM; Patel NK; Chhatwal J; Vahdat V; Pomerantsev EV; Albaghdadi M; Sakhuja R; Rosenzweig A; Elmariah S
Circ Cardiovasc Interv; 2020 Nov; 13(11):e010027. PubMed ID: 33167699
[TBL] [Abstract][Full Text] [Related]
15. Why Fibrinolytic Therapy for ST-Segment-Elevation Myocardial Infarction in the COVID-19 Pandemic Is Not Your New Best Friend.
Kirtane AJ; Bangalore S
Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006885. PubMed ID: 32339025
[No Abstract] [Full Text] [Related]
16. Characteristics and Outcomes in Patients Presenting With COVID-19 and ST-Segment Elevation Myocardial Infarction.
Hamadeh A; Aldujeli A; Briedis K; Tecson KM; Sanz-Sánchez J; Al Dujeili M; Al-Obeidi A; Diez JL; Žaliūnas R; Stoler RC; McCullough PA
Am J Cardiol; 2020 Sep; 131():1-6. PubMed ID: 32732010
[TBL] [Abstract][Full Text] [Related]
17. Temporary Emergency Guidance to STEMI Systems of Care During the COVID-19 Pandemic: AHA's Mission: Lifeline.
American Heart Association’s Mission: Lifeline and Get With The Guidelines Coronary Artery Disease Advisory Work Group and the Council on Clinical Cardiology’s Committees on Acute Cardiac Care and General Cardiology and Interventional Cardiovascular Care*
Circulation; 2020 Jul; 142(3):199-202. PubMed ID: 32363905
[No Abstract] [Full Text] [Related]
18. ST-segment Elevation, Myocardial Injury, and Suspected or Confirmed COVID-19 Patients: Diagnostic and Treatment Uncertainties.
Bennett CE; Anavekar NS; Gulati R; Singh M; Kane GC; Sandoval Y; Foley TA; Jaffe AS; Sandhu GS; Bell MR; Askew JW
Mayo Clin Proc; 2020 Jun; 95(6):1107-1111. PubMed ID: 32414550
[No Abstract] [Full Text] [Related]
19. A treatment strategy for acute myocardial infarction and personal protection for medical staff during the COVID-19 epidemic: the Chinese experience.
Han Y
Eur Heart J; 2020 Jun; 41(23):2148-2149. PubMed ID: 32338764
[No Abstract] [Full Text] [Related]
20. COVID-19 pandemic and infarctions: another call to reorganise our healthcare systems.
De Filippo O; D'Ascenzo F; Deferrari GM
Heart; 2020 Dec; 106(23):1786-1787. PubMed ID: 33087411
[No Abstract] [Full Text] [Related]
[Next] [New Search]
